Xencor, Inc. (XNCR)
33.26
-0.75
(-2.21%)
USD |
NASDAQ |
Nov 20, 16:00
33.28
+0.02
(+0.06%)
After-Hours: 20:00
Xencor Debt to Equity Ratio : 0.2859 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.2859 |
| June 30, 2026 | 0.338 |
| March 31, 2026 | 0.3397 |
| December 31, 2025 | 0.2954 |
| September 30, 2025 | 0.3237 |
| June 30, 2025 | 0.3433 |
| March 31, 2025 | 0.3473 |
| December 31, 2024 | 0.3423 |
| September 30, 2024 | 0.1196 |
| June 30, 2024 | 0.1554 |
| March 31, 2024 | 0.1458 |
| December 31, 2023 | 0.1248 |
| September 30, 2023 | 0.0908 |
| June 30, 2023 | 0.0867 |
| March 31, 2023 | 0.0867 |
| December 31, 2022 | 0.082 |
| September 30, 2022 | 0.0596 |
| June 30, 2022 | 0.056 |
| March 31, 2022 | 0.0457 |
| December 31, 2021 | 0.0463 |
| September 30, 2021 | 0.0553 |
| June 30, 2021 | 0.0078 |
| March 31, 2021 | 0.0191 |
| December 31, 2020 | 0.0203 |
| September 30, 2020 | 0.0168 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.017 |
| March 31, 2020 | 0.0172 |
| December 31, 2019 | 0.0181 |
| September 30, 2019 | 0.0185 |
| June 30, 2019 | 0.0195 |
| March 31, 2019 | 0.02 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0001 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Iovance Biotherapeutics, Inc. | 0.0556 |
| Ironwood Pharmaceuticals, Inc. | -3.459 |
| UroGen Pharma Ltd. | -1.568 |
| MeiraGTx Holdings Plc | 0.6223 |
| IDEAYA Biosciences, Inc. | 0.0272 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 770.50M |
| Total Liabilities (Quarterly) | 210.07M |
| Shareholders Equity (Quarterly) | 560.44M |
| Current Ratio | 6.538 |
| Net Debt Paydown Yield | 0.57% |